Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men
Folia Histochemica et Cytobiologica · 2023
DOI: 10.5603/fhc.97035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Histochemica et Cytobiologica, 2023. Verfasst von Elvir Zvrko und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Otorhinolaryngology, Clinical Center of Montenegro, Podgorica, Montenegro. elvir@zvrko.me. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Laryngeal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
In this study we analyzed CD105 (endoglin) and E-cadherin expression in laryngeal squamous cell carcinoma (LSCC) to evaluate their clinicopathologic significance. Material and methods. Expression of CD105 and E-cadherin was examined immunohistochemically using paraffin-embedded archival tissues of 72 (35 glottic and 37 supraglottic) previously untreated LSCC male patients. The mean value of the positively-stained microvessels for CD105 counted in four hot spots for each case was used as the final intratumoralmicrovessel density (MVD). A staining score of E-cadherin was calculated based on the percentage of cells stained (0–100%).
Results
MVD was significantly higher in patients with advanced TNM stage (P = 0.004) and younger than 65 (P = 0.008). Nodal metastases were more frequent in the cases with low E-cadherin expression (P = 0.000). Tumor recurrence was associated with advanced TNM stage (P = 0.035) and high MVD (P = 0.002). A high MVD was an independent predictor of malignancy recurrence (P = 0.021). The log-rank test showed a significant difference in the disease-free interval in patients stratified according to the MVD value (P = 0.016). Spearman’s rank correlation test did not show a significant correlation between E-cadherin and CD105 expression.
Conclusions
CD105-assessed MVD and expression of E-cadherin are promising prognostic factors for the outcome of patients with LSCC. Increased expression of CD105 could help predict patients with an increased risk of developing loco-regional recurrence after surgical treatment. Decreased E-cadherin expression is a potential predictor of lymph node metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Otorhinolaryngology, Clinical Center of Montenegro, Podgorica, Montenegro. elvir@zvrko.me.
- Faculty of Medicine, University of Montenegro, Podgorica, Montenegro. elvir@zvrko.me.
- Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.
- Center of Pathology, Clinical Center of Montenegro, Podgorica, Montenegro.
ORCID-Profile: Elvir Zvrko
Zitieren
APA
Zvrko, E., & Vuckovic, L. (2023). Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men. Folia Histochemica et Cytobiologica. https://doi.org/10.5603/fhc.97035
Vancouver
Zvrko E, Vuckovic L. Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men. Folia Histochemica et Cytobiologica. 2023. doi:10.5603/fhc.97035
BibTeX
@article{Zvrko2023,
author = {Zvrko, Elvir and Vuckovic, Ljiljana},
title = {Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men},
journal = {Folia Histochemica et Cytobiologica},
year = {2023},
doi = {10.5603/fhc.97035}
}
EUVIMED